Clinical Alternatives for Reducing Harm Using E-cigarettes

Summary

For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).

Eligibility

Inclusion Criteria:

* age 21+,
* identified as smoking in their medical record and self-report of current smoking within the past 30 days
* refused traditional treatment options through the opt-out HCC Tobacco Treatment Program
* English speaking;

Exclusion Criteria:

* currently taking part in any TTP or using cessation medication (i.e., taking NRT or other cessation medications, enrolled in the Quitline, or in another study),
* use of e-cigarettes in the past 30 days,
* currently imprisoned,
* pregnant women.

Conditions4

Locations1 site

Browse More Trials